Drug Reference

Trandolapril / Verapamil

ACE inhibitors and calcium channel blockers

Fact box

Therapeutic class: ACE inhibitors and calcium channel blockers

Available as

2 MG · Extended Release Oral Capsule1 MG · Extended Release Oral Tablet2 MG · Extended Release Oral Tablet4 MG · Extended Release Oral Tablet

Multi-ingredient product

TrandolaprilVerapamil

This medicine contains more than one active ingredient. To avoid attributing one component’s information to the whole product, structured label sections aren’t shown here — see the component pediatric notes below and the full combination label on DailyMed.

Current FDA labels (DailyMed)

TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [GLENMARK PHARMACEUTICALS INC., USA]
TARKA (TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE) TABLET, FILM COATED, EXTENDED RELEASE [PHYSICIANS TOTAL CARE, INC.]

5 marketed products on record (RxNorm)

Authoritative sources

DailyMed — current FDA labeling →
LactMed — breastfeeding safety (NLM) →
MedlinePlus — plain-language drug info →
RxNorm (NLM) →

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.